ArticleLeukemia2018

Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.

M Waibel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.